Introduction {#Sec1}
============

Bloodstream infections (BSI) are an important cause of mortality, prolonged stay and excess healthcare costs in paediatric intensive care units (PICU) \[[@CR1]--[@CR3]\]. An estimated 70 % of BSIs occurring in PICU are thought to be related to the use of central venous catheters (CVCs) \[[@CR4]\]. Over the past decade, implementation of care bundles to improve the sterility of CVC insertion have resulted in significant reductions in the rate of catheter-related BSI in adult and paediatric ICUs worldwide \[[@CR5]--[@CR9]\].

Risk factors for BSI in critically ill children with a CVC relate to patient susceptibility (e.g. immunodeficiency, need for blood transfusion and renal replacement therapy) and the catheter (sterility of insertion, type of catheter material, number of CVCs and duration of catheterisation) \[[@CR10]--[@CR12]\]. The potential for full aseptic technique during CVC insertion is likely to be compromised during emergency stabilisation. This has resulted in national guidelines recommending elective replacement of the CVC after admission to intensive care \[[@CR13]--[@CR17]\]. Evidence from single-centre studies showing an increased risk of BSI in patients whose CVC was inserted outside the ICU underpins these guidelines, but partly predates major improvements in infection control across the UK National Health Service, including specific bundles of care to improve sterile procedures during CVC insertion \[[@CR13]\].

We use national linked data to determine how trends in BSI differed in children admitted after inter-hospital transfer compared with within-hospital admission to PICU. Our study covers a period of 10 years, during which time national quality improvement initiatives related to CVC care were implemented (*Saving Lives* in 2007 and *Matching Michigan* in 2009) \[[@CR18], [@CR19]\]. Falling rates of BSI over recent years have not been restricted to children with CVCs but have been observed in all children in PICU (who may be subjected to a number of invasive procedures). We therefore chose to include all children admitted to PICU in this study.

Materials and methods {#Sec2}
=====================

Study population {#Sec3}
----------------

The study population comprised all admissions between March 2003 and December 2012 of children aged \<16 years to the 22 PICUs in England and Wales with at least 200 admissions per year. Data were extracted from the Paediatric Intensive Care Audit Network (PICANet), which records source of admission and clinical information but does not capture information on BSI or CVC insertion \[[@CR20]\]. All PICUs in England and Wales have contributed data to PICANet since March 2003.

We linked records of PICU admissions to records of BSI recorded in the national infection surveillance system in England and Wales (LabBase2). This is a voluntary system coordinated by Public Health England (PHE) \[[@CR21]\]. Hospital laboratories are requested to report all clinically significant isolates from blood, but there is variation in how clinical significance is defined and hence in judging which isolates should be reported. We have previously reported 80--95 % ascertainment of BSI by Labbase2 and shown that incomplete reporting is not related to patient or organism characteristics \[[@CR22]\]. The linked dataset comprised admissions to 20/22 PICUs in England and Wales (two PICUs did not report sufficient data to LabBase2 during the study period).

A detailed description of the linkage between PICANet and LabBase2 has been reported elsewhere \[[@CR22]\]. Briefly, a combination linkage methods were used to identify PICANet admission records that had a corresponding record of BSI in LabBase2, based on agreement between NHS number, hospital number, first name, surname, date of birth, postcode, sex and location (laboratory and hospital) \[[@CR23]\].

Case definition {#Sec4}
---------------

We defined an episode of BSI as any positive blood culture with one or more organisms isolated from any blood sample taken on the same day. Since PICANet does not routinely capture the presence of a CVC during PICU admission, we were unable to determine whether BSI recorded in LabBase2 were related to CVCs or not. Our analysis therefore studied all BSI, and includes any CVC-related or CVC-associated BSI as well as BSI from ventilator-associated pneumonia or catheter-associated urinary tract infection. As a sensitivity analysis, we restricted analyses to children receiving vasoactive agents and requiring invasive ventilation, as these children would be very likely to also require a CVC.

We defined PICU-acquired BSI as any BSI occurring from samples taken from 2 days after admission to 2 days after discharge from PICU. This definition excluded samples taken on the day of admission or the day after admission to PICU, as positive samples on these days may be more reflective of events leading up to admission. We included samples taken on the 2 days following discharge from PICU and so children staying \<2 days could have a PICU-acquired BSI if a sample was taken in the 2 days following discharge. This definition may mean that a small proportion of PICU-acquired occurring in the first 2 days of admission are missed (\<5 %) \[[@CR24]\].

As a secondary analysis, we also evaluated *early* BSI in PICU (occurring between days 0--7 of admission). This analysis aimed to capture any BSI occurring in the first week of admission (i.e. BSI occurring in the first 2 days of PICU admission and those occurring between days 2--7 of PICU admission). We hypothesised that any effect on BSI of CVC insertion during emergency stabilisation at another hospital could be most apparent within the first week of PICU admission, based on data showing the risk of BSI from insertion of non-cuffed CVCs to be highest in the first few days \[[@CR25]\].

Repeated samples with positive cultures of the same organism within 14 days were treated as the same episode. This meant that, for children who already had BSI on admission, we only included PICU-acquired BSI in analysis if the organism from samples taken after admission was a different organism. As laboratory records included the date but not the time the specimen was taken, some included samples may have been taken between 24 and 48 h after admission to PICU.

Comparisons of PICU-acquired BSI were restricted to emergency admissions (unplanned admissions as defined within PICANet), since children admitted electively would likely have had a CVC inserted under sterile conditions in the operating theatre. Children with unknown source or type of admission were excluded (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Study profile. *Dashed box* records included in analysis

Statistical analysis {#Sec5}
--------------------

Univariable associations between clinical characteristics and PICU-acquired BSI were assessed using Chi-squared tests (categorical variables) or Mann--Whitney tests (continuous variables). Analysis was performed using Stata 12 \[[@CR26]\].

The primary analysis determined whether trends (change over time) in BSI per 1,000 bed-days differed between children with an emergency admission to PICU after inter-hospital transfer compared to within-hospital admission. These analyses used Poisson regression, adjusting for potential confounders including primary diagnosis at admission, ventilation status and Paediatric Index of Mortality (PIM2) score (see Table [1](#Tab1){ref-type="table"}) \[[@CR27]\]. Differences in trends in PICU-acquired BSI by source of admission (inter-hospital transfer versus within-hospital admission) were assessed through the inclusion of an interaction term for trend and source of admission.Table 1Characteristics of emergency admissions to UK PICUs for children aged \<16 years, 2003--2012 (univariable analysis)Admissions with no PICU-acquired BSI (*n* = 61,162)Admissions with PICU-acquired BSI (*n* = 1,353)*p* valueAdmission source Inter-hospital transfer32,082 (52 %)779 (58 %)\<0.0001 Within-hospital admission29,080 (48 %)574 (42 %)Sex Male35,349 (58 %)762 (56 %)0.174 Female25,767 (42 %)591 (44 %) Unknown46 (0 %)0 (0 %)Age \<1 year28,472 (47 %)773 (57 %)\<0.0001 1--4 years16,407 (27 %)334 (25 %) 5--10 years8,520 (14 %)139 (10 %) 11--15 years7,763 (13 %)107 (8 %)Vasoactive agents14,768 (24 %)774 (57 %)\<0.0001Renal support1,910 (3 %)210 (15 %)\<0.0001Admitted after surgery5,415 (9 %)86 (6 %)0.001PIM2 \<1 %12,499 (20 %)110 (8 %)\<0.0001 1--5 %26,393 (43 %)425 (31 %) 5--15 %15,785 (26 %)496 (37 %) 15--30 %3,626 (6 %)194 (14 %) 30 %+2,860 (5 %)127 (9 %)Primary diagnosis Cardiovascular8,264 (14 %)299 (22 %)\<0.0001 Respiratory22,847 (37 %)373 (28 %) Infection4,899 (8 %)254 (19 %) Other25,152 (41 %)427 (32 %)Ventilation status Neither17,463 (29 %)163 (12 %)\<0.0001 Non-invasive only3,740 (6 %)23 (2 %) Invasive only31,860 (52 %)752 (56 %) Both7,298 (12 %)387 (29 %) Unknown800 (1 %)29 (2 %)PICU size (average admissions per year) 0--65023,059 (38 %)355 (26 %)\<0.0001 650--100024,718 (40 %)628 (46 %) \>100013,385 (22 %)370 (27 %)PICU type General27,656 (45 %)476 (35 %)\<0.0001 Mixed32,837 (54 %)850 (63 %) Cardiac669 (1 %)27 (2 %)Area admitted from A&E16,907 (28 %)227 (17 %)\<0.0001 HDU3,850 (6 %)94 (7 %) ICU / PICU / NICU8,075 (13 %)272 (20 %) Other intermediate care1,188 (2 %)38 (3 %) Recovery only264 (0 %)5 (0 %) Theatre and recovery7,025 (11 %)118 (9 %) Ward20,818 (34 %)539 (40 %) X-ray/endoscopy/CT474 (1 %)4 (0 %) Unknown2,560 (4 %)57 (4 %)

Time to PICU-acquired BSI was defined as the number of days between admission and the date of the first PICU-acquired BSI. The difference in time to PICU-acquired BSI between inter-hospital and within-hospital transfers was assessed using multivariable Cox regression. Random effects for PICUs were included in models to account for clustering of admissions within PICUs.

We also separately analysed PICU-acquired BSI due to skin and non-skin organisms, as we hypothesised that infection control practices might have had more impact on BSI due to skin organisms acquired during CVC insertion. Skin organisms were defined as coagulase negative staphylococcus, *Staphylococcus epidermidis, Corynebacterium* spp. or *Proprionibacterium* spp. All other organisms were classified as non-skin organisms. As BSI could be due to skin organisms, non-skin organisms or both, numbers of BSI due to skin and non-skin organisms exceed the total number of BSI.

Results {#Sec6}
=======

Bloodstream infections in PICU {#Sec7}
------------------------------

Figure [1](#Fig1){ref-type="fig"} shows the number of records included in the analysis. Admission characteristics are shown in Table [1](#Tab1){ref-type="table"}. For the 62,515 emergency admissions between March 2003 and December 2012, there were 1628 episodes of PICU-acquired BSI, and 1353 admissions (2.2 %) experienced at least one PICU-acquired BSI. This equated to an overall rate of 4.97 (95 % CI 4.73--5.22) PICU-acquired BSI per 1,000 bed-days.

The percentage of admissions acquiring BSI following inter-hospital transfer (56 %) was greater than for within-hospital admissions (42 %). However, after adjusting for significant risk factors (calendar period of admission measured by quarter-year, age, renal support, diagnosis group, and ventilation status, see Table 1 in Supplement) there was no significant difference in rates of PICU-acquired BSI by source of admission. The incidence-rate ratio for inter-hospital transfer versus within-hospital admission was 0.97 (95 % CI 0.87--1.07). There was, however, a significant interaction between source of admission and time, with rates decreasing more rapidly for inter-hospital transfers (17.0 %; 95 % CI 14.9--19.0 % per year) compared with 12.4 % (95 % CI 9.9--14.9 % per year) for within-hospital admissions (*p* = 0.026).

The sensitivity analysis included 14,393 children who required invasive ventilation and who received vasoactive agents. For these admissions, there were 937 episodes of PICU-acquired BSI, and 763 admissions (5.3 %) experienced at least one PICU-acquired BSI (7.03 per 1,000 bed-days; 95 % CI 6.09--7.97). The incidence-rate ratio for inter-hospital transfer versus within-hospital admission was similar to that in the main analysis: 0.98 (95 % CI 0.86--1.13). In this group, who were likely to have required CVCs, rates also decreased more rapidly for inter-hospital transfers (17.5; 95 % CI 17.0--18.0) compared with 12.6 (95 % CI 10.4--14.5) for within-hospital admissions (*p* = \<0.001).

In the secondary analysis restricting the outcome to early BSI (occurring between days 0--7 of admission), there was no significant difference in rates by source of admission (incidence-rate ratio for inter-hospital transfer vs. within-hospital admission = 0.97; 95 % CI 0.89--1.05). Trends were similar in both groups (*p* value for interaction term = 0.66).

Overall, non-skin organisms dominated as causative organisms for PICU-acquired BSI (3.76; 95 % CI 3.61--3.91 per 1,000 bed-days for non-skin organisms vs. 1.61; 95 % CI 1.51--1.71 for skin organisms). This was consistent for both inter-hospital transfers and within-hospital admissions. Trends seen in PICU-acquired BSI due to skin organisms and due to non-skin organisms reflected those seen overall (Fig. [2](#Fig2){ref-type="fig"}). There was no significant difference in rates or trends of either type of organism between inter-hospital transfers or within-hospital admissions.Fig. 2Trends in PICU-acquired bloodstream infection (log-scale) due to skin organisms or non-skin organisms by admission source and quarter-year of admission. *Symbols* observed rates, *lines* adjusted smoothed rates

Time to PICU-acquired BSI {#Sec8}
-------------------------

The percentage of admissions acquiring BSI in PICU increased with length of stay (Table [2](#Tab2){ref-type="table"}). The median time to PICU-acquired BSI did not differ between inter-hospital transfers (7 days from admission; IQR 4--13) and within-hospital admissions (8 days; IQR 4--15). Between 2003 and 2012, there was no significant difference by admission source in time to PICU-acquired BSI (hazard ratio for inter-hospital transfers versus within-hospital admissions = 0.93; 95 % CI 0.83--1.04, Fig. [3](#Fig3){ref-type="fig"}) or for early BSI (hazard ratio = 0.96; 95 % CI 0.87--1.06).Table 2Percentage of admissions with PICU-acquired BSI by length of stayPatient length of stay*n* admissionsAdmissions with PICU-acquired BSI^a^Admissions with PICU-acquired BSI due to skin organisms^a^Admissions with PICU-acquired BSI due to non-skin organisms^a^Admissions with early BSI^b^\<2 days27,03186 (0.3 %)45 (0.2 %)110 (0.4 %)733 (2.7 %)2 to \<7 days23,337337 (1.4 %)149 (0.6 %)367 (1.6 %)1,110 (4.8 %)7 to \<14 days7,712314 (4.1 %)127 (1.7 %)316 (4.1 %)433 (5.6 %)14 to \<21 days2,185206 (9.4 %)101 (4.6 %)178 (8.1 %)133 (6.1 %)21 to \<28 days881110 (12.5 %)49 (5.6 %)109 (12.4 %)54 (6.1 %)28+ days1,369300 (21.9 %)172 (12.5 %)322 (23.5 %)65 (4.7 %)^a^PICU-acquired BSI occurring between 2 days after admission and up to 2 days after discharge^b^Early BSI occurring in days 0--7 of admissionFig. 3Survival curve for cumulative incidence of PICU-acquired BSI by admission source

The median time to PICU-acquired BSI due to skin organisms was 8 (IQR 4--16) and 7 (IQR 4--13) days for non-skin organisms. There was no significant difference in time to PICU-acquired BSI either due to skin organisms (hazard ratio for inter-hospital transfer vs. within-hospital admissions = 0.90; 95 % CI 0.73--1.13) or non-skin organisms (hazard ratio = 0.91; 95 % CI 0.79--1.04).

Discussion {#Sec9}
==========

Our study shows that, in England and Wales, the risk of BSI acquired in PICU did not vary according to whether a child had an emergency admission to PICU following inter-hospital transfer from another hospital or were within-hospital admissions. Previously described risk factors for BSI, such as need for renal support and longer PICU stay, were associated with a greater risk of BSI in our study \[[@CR10], [@CR12], [@CR28], [@CR29]\]. Rates of PICU-acquired BSI have continued to fall over the past decade, at a greater rate in inter-hospital transfers than in within-hospital admissions, coincident with several national quality improvement initiatives \[[@CR18], [@CR19]\]. Our findings are important in guiding national policy on where future efforts to reduce BSI in PICU should be targeted.

Our study is the first to analyse BSI data at a national level in emergency admissions to PICUs in England and Wales. The main strength of our study was the national coverage of our linked dataset and the long study period of 10 years. We were also able to analyse microbiological data on a large proportion of all PICU admissions during the study period (\>70 %). We chose to study all BSI, rather than just BSI related to the presence of a CVC, since children on a PICU are subjected to many invasive procedures, all of which may increase the risk of BSI.

The main weakness of our study, which limits our ability to directly compare our results with previous single-centre studies, was that the linked national dataset did not contain information on which patients had a CVC during their stay in PICU (or where it was inserted and the circumstances surrounding its insertion). As such, any true differences in CVC insertion practice between inter-hospital transfers and within-hospital admissions contributing to the development of PICU BSI could have been masked, biasing our results towards the null. However, since approximately 40--60 % of emergency admissions to PICU require a CVC (unpublished audit data), and since rates of BSI in children without CVCs are low, differences in trends in BSI seen in our study seen between inter-hospital and within-hospital admissions are likely to be related to the use of CVCs. Furthermore, our sensitivity analysis evaluating rates in children requiring vasoactive agents and invasive ventilation showed results almost identical to those in all children, although absolute BSI rates were higher in this group.

There are several potential explanations for our findings. First, the fact that BSI rates decreased more rapidly in the inter-hospital transfer group over the years may be related to differences between the groups studied despite adjustment for case mix and severity of illness, with respect to the type of CVC used (CVCs in inter-hospital transfers were more likely to be short-term non-tunnelled catheters, whereas within-hospital admissions were more likely to have long-term tunnelled catheters), patient susceptibility (within-hospital admissions more likely to have impaired host defence), presence of co-morbidities (more frequent in within-hospital admissions) and length of CVC use. Second, inter-hospital transfers may have benefited more from the implementation of national quality improvement initiatives. Third, the fact that there was no difference in the time to BSI within the first week between the groups may be explained by the use of antibiotics, which may have delayed the onset of insertion-related BSI beyond the first week of admission in inter-hospital transfers.

Our study demonstrates that routine replacement of CVCs inserted in trauma and other emergencies is not justified in critically ill children, as, in England and Wales, children with CVCs inserted following stabilisation are not at a higher risk of BSI. Further, since the rate of BSI has reduced significantly over the past decade, future attempts to eliminate BSI may need to focus more on practice related to the maintenance of CVCs. Studies from other settings have emphasised the importance of CVC maintenance-related care bundles in the reduction of BSI in PICUs, particularly due to the frequent use of tunnelled long-term CVCs in this population \[[@CR30], [@CR31]\]. Further research focusing on the influence of co-morbidities, CVC type and exposure, and differential use of antibiotics, on BSI rates in national PICU cohorts is required.

**Take-home message:**

Evidence underpinning national guidance to replace central venous catheters after admission to intensive care predates major quality improvement initiatives and improved infection control in UK paediatric intensive care units. We used national linked data to demonstrate that inter-hospital transfer is no longer a significant risk factor for bloodstream infection and suggest that strategies to further reduce bloodstream infection should focus on maintaining sterile procedures after admission.
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